Emerging rules for subunit-based, multiantigenic, multistage chemically synthesized vaccines

Accounts of Chemical Research

Volumn 41, Issue 3, 2008, Pages 377-386

  Patarroyo, Manuel Elkin ^c   Patarroyo, Manuel Alfonso ^a,b,c  

^a UNIVERSIDAD DEL ROSARIO   (Colombia)

^b UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

^c FUNDACIÓN INSTITUTO DE INMUNOLOGÍA DE COLOMBIA FIDIC   (Colombia)

Author keywords

[No Author keywords available]

Indexed keywords

MALARIA VACCINE; PARASITE ANTIGEN; SUBUNIT VACCINE;

ANIMAL; AOTUS; HUMAN; IMMUNOLOGY; MALARIA FALCIPARUM; PARASITOLOGY; PATHOGENICITY; PLASMODIUM FALCIPARUM; REVIEW; SYNTHESIS;

ANIMALS; ANTIGENS, PROTOZOAN; AOTUS TRIVIRGATUS; HUMANS; MALARIA VACCINES; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM; VACCINES, SUBUNIT;

EID: 42449128753     PISSN: 00014842     EISSN: None     Source Type: Journal    
DOI: 10.1021/ar700120t     Document Type: Review

References (64)

1. Bozdech, Z.; Llinas, M.; Pulliam, B. L.; Wong, E. D.; Zhu, J.; DeRisi, J. L. The transcriptome of the intraerythrocytic developmental cycle of Plasmodium falciparum. PLoS Biol. 2003, 1, E5.
2. Le Roch, K. G.; Zhou, Y.; Blair, P. L.; Grainger, M.; Moch, J. K.; Haynes, J. D.; De La Vega, P.; Holder, A. A.; Batalov, S.; Carucci, D. J.; Winzeler, E. A. Discovery of gene function by expression profiling of the malaria parasite life cycle. Science 2003, 301, 1503-1508.
3. Garcia, J. E.; Puentes, A.; Patarroyo, M. E. Developmental biology of sporozoite-host interactions in Plasmodium falciparum malaria: implications for vaccine design. Clin. Microbiol. Rev. 2006, 4, 686-707.
4. Kappe, S. H.; Buscaglia, C. A.; Nussenzweig, V. Plasmodium sporozoite molecular cell biology. Annu. Rev. Cell. Dev. Biol. 2004, 20, 29-59.
5. Guerin-Marchand, C.; Druilhe, P.; Galey, B.; Londono, A.; Patarapotikul, J.; Beaudoin, R. L.; Dubeaux, C.; Tartar, A.; Mercereau-Puijalon, O.; Langsley, G. A liver-stage-specific antigen of Plasmodium falciparum characterized by gene cloning. Nature 1987, 329, 164-167.
6. Ishino, T.; Yano, K.; Chinzei, Y.; Yuda, M. Cell-passage activity is required for the malarial parasite to cross the liver sinusoidal cell layer. PLoS Biol. 2004, 2, E4.
7. Holder, A. A.; Freeman, R. R. Biosynthesis and processing of a Plasmodium falciparum schizont antigen recognized by immune serum and a monoclonal antibody. J. Exp. Med. 1982, 156, 1528-1538.
8. Fenton, B.; Clark, J. T.; Khan, C. M.; Robinson, J. V.; Walliker, D.; Ridley, R.; Scaife, J. G.; McBride, J. S. Structural and antigenic polymorphism of the 35- to 48-kilodalton merozoite surface antigen (MSA-2) of the malaria parasite Plasmodium falciparum. Mol. Cell. Biol. 1991, 11, 963-971.
9. Oeuvray, C.; Bouharoun-Tayoun, H.; Grass-Masse, H.; Lepers, J. P.; Ralamboranto, L.; Tartar, A.; Druilhe, P. A novel merozoite surface antigen of Plasmodium falciparum (MSP-3) identified by cellular-antibody cooperative mechanism antigenicity and biological activity of antibodies. Mem. Inst. Oswaldo Cruz 1994, 89, 77-80.
10. Trucco, C.; Fernandez-Reyes, D.; Howell, S.; Stafford, W. H.; Scott-Finnigan, T. J.; Grainger, M.; Ogun, S. A.; Taylor, W. R.; Holder, A. A. The merozoite surface protein 6 gene codes for a 36 kDa protein associated with the Plasmodium falciparum merozoite surface protein-1 complex. Mol. Biochem. Parasitol. 2001, 112, 91-101.
11. Peterson, M. G.; Marshall, V. M.; Smythe, J. A.; Crewther, P. E.; Lew, A.; Silva, A.; Anders, R. F.; Kemp, D. J. Integral membrane protein located in the apical complex of Plasmodium falciparum. Mol. Cell. Biol. 1989, 9, 3151-3154.
12. Gilberger, T. W.; Thompson, J. K.; Triglia, T.; Good, R. T.; Duraisingh, M. T.; Cowman, A. F. A novel erythrocyte binding antigen-175 paralogue from Plasmodium falciparum defines a new trypsin-resistant receptor on human erythrocytes. J. Biol. Chem. 2003, 278, 14480-14486.
13. Thompson, J. K.; Triglia, T.; Reed, M. B.; Cowman, A. F. A novel ligand from Plasmodium falciparum that binds to a sialic acid-containing receptor on the surface of human erythrocytes. Mol. Microbiol. 2001, 41, 47-58.
14. Sim, B. K.; Orlandi, P. A.; Haynes, J. D.; Klotz, F. W.; Carter, J. M.; Camus, D.; Zegans, M. E.; Chulay, J. D. Primary structure of the 175K Plasmodium falciparum erythrocyte binding antigen and identification of a peptide which elicits antibodies that inhibit malaria merozoite invasion. J. Cell Biol. 1990, 111, 1877-1884.
15. Cooper, J. A.; Ingram, L. T.; Bushell, G. R.; Fardoulys, C. A.; Stenzel, D.; Schofield, L.; Saul, A. J. The 140/130/105 kilodalton protein complex in the rhoptries of Plasmodium falciparum consists of discrete polypeptides. Mol. Biochem. Parasitol. 1988, 29, 251-260.
16. Baldi, D. L.; Good, R.; Duraisingh, M. T.; Crabb, B. S.; Cowman, A. F. Identification and disruption of the gene encoding the third member of the low-molecular-mass rhoptry complex in Plasmodium falciparum. Infect. Immun. 2002, 70, 5236-5245.
17. Kaneko, O.; Yim Lim, B. Y.; Iriko, H.; Ling, I. T.; Otsuki, H.; Grainger, M.; Tsuboi, T.; Adams, J. H.; Mattei, D.; Holder, A. A.; Torii, M. Apical expression of three RhopH1/Clag proteins as components of the Plasmodium falciparum RhopH complex. Mol. Biochem. Parasitol. 2005, 143, 20-28.
18. Baum, J.; Maier, A. G.; Good, R. T.; Simpson, K. M.; Cowman, A. F. Invasion by P. falciparum merozoites suggests a hierarchy of molecular interactions. PLoS Pathog. 2005, 1, e37.
19. Nery, S.; Deans, A. M.; Mosobo, M.; Marsh, K.; Rowe, J. A.; Conway, D. J. Expression of Plasmodium falciparum genes involved in erythrocyte invasion varies among isolates cultured directly from patients. Mol. Biochem. Parasitol. 2006, 149, 208-215.
20. Miller, L. H.; Roberts, T.; Shahabuddin, M.; McCutchan, T. F. Analysis of sequence diversity in the Plasmodium falciparum merozoite surface protein-1 (MSP-1). Mol. Biochem. Parasitol. 1993, 59, 1-14.
21. McColl, D. J.; Anders, R. F. Conservation of structural motifs and antigenic diversity in the Plasmodium falciparum merozoite surface protein-3 (MSP-3). Mol. Biochem. Parasitol. 1997, 90, 21-31.
22. Pearce, J. A.; Triglia, T.; Hodder, A. N.; Jackson, D. C.; Cowman, A. F.; Anders, R. F. Plasmodium falciparum merozoite surface protein 6 is a dimorphic antigen. Infect. Immun. 2004, 72, 2321-2328.
23. Gilbert, S. C.; Plebanski, M.; Gupta, S.; Morris, J.; Cox, M.; Aidoo, M.; Kwiatkowski, D.; Greenwood, B. M.; Whittle, H. C.; Hill, A. V. Association of malaria parasite population structure, HLA, and immunological antagonism. Science 1998, 279, 1173-1177.
24. Lee, E. A.; Flanagan, K. L.; Minigo, G.; Reece, W. H.; Bailey, R.; Pinder, M.; Hill, A. V.; Plebanski, M. Dimorphic Plasmodium falciparum merozoite surface protein-1 epitopes turn off memory T cells and interfere with T cell priming. Eur. J. Immunol. 2006, 36, 1168-1178.
25. Patarroyo, M. E.; Romero, P.; Torres, M. L.; Clavijo, P.; Moreno, A.; Martínez, A.; Rodríguez, R.; Guzman, F.; Cabezas, E. Induction of protective immunity against experimental infection with malaria using synthetic peptides. Nature 1987, 328, 629-632.
26. Patarroyo, M. E.; Amador, R.; Clavijo, P.; Moreno, A.; Guzman, F.; Romero, P.; Tascon, R.; Franco, A.; Murillo, L. A.; Ponton, G.; Trujillo, G. A synthetic vaccine protects humans against challenge with asexual blood stages of Plasmodium falciparum malaria. Nature 1988, 332, 158-161.
27. Valero, M. V.; Amador, L. R.; Galindo, C.; Figueroa, J.; Bello, M. S.; Murillo, L. A.; Mora, A. L.; Patarroyo, G.; Rocha, C. L.; Rojas, M.; Aponte, J. J.; Sarmiento, L. E.; Lozada, D. M.; Coronell, C. G.; Ortega, N. M.; Rosas, J. E.; Alonso, P. L.; Patarroyo, M. E. Vaccination with SPf66, a chemically synthesised vaccine, against Plasmodium falciparum malaria in Colombia. Lancet 1993, 341, 705-710.
28. Alonso, P. L.; Smith, T.; Schellenberg, J. R.; Masanja, H.; Mwankusye, S.; Urassa, H.; Bastos de Azevedo, I.; Chongela, J.; Kobero, S.; Menendez, C. Randomised trial of efficacy of SPf66 vaccine against Plasmodium falciparum malaria in children in southern Tanzania. Lancet 1994, 344, 1175-1181.
29. Noya, O.; Gabaldon Berti, Y.; Alarcon de Noya, B.; Borges, R.; Zerpa, N.; Urbaez, J. D.; Madonna, A.; Garrido, E.; Jimenez, M. A.; Borges, R. E. A population-based clinical trial with the SPf66 synthetic Plasmodium falciparum malaria vaccine in Venezuela. J. Infect. Dis. 1994, 170, 396-402.
30. Nosten, F.; Luxemburger, C.; Kyle, D. E.; Ballou, W. R.; Wittes, J.; Wah, E.; Chongsuphajaisiddhi, T.; Gordon, D. M.; White, N. J.; Sadoff, J. C.; Heppner, D. G. Randomised double-blind placebo-controlled trial of SPf66 malaria vaccine in children in northwestern Thailand. Shoklo SPf66 Malaria Vaccine Trial Group. Lancet 1996, 348, 701-707.
31. Calvo, M.; Guzman, F.; Perez, E.; Segura, C. H.; Molano, A.; Patarroyo, M. E. Specific interactions of synthetic peptides derived from P. falciparum merozoite proteins with human red blood cells. Pept. Res. 1991, 4, 324-333.
32. Patarroyo, M. E.; Vinasco, J.; Amador, R.; Espejo, F.; Silva, Y.; Moreno, A.; Rojas, M.; Mora, A. L.; Salcedo, M.; Valero, V.; Goldberg, A. K.; Kalil, J. Genetic control of the immune response to a synthetic vaccine against Plasmodium falciparum. Parasite Immunol 1991, 13, 509-516.
33. Murillo, L. A.; Rocha, C. L.; Mora, A. L.; Kalil, J.; Goldenberg, A. K.; Patarroyo, M. E. Molecular analysis of HLA DR4-beta 1 gene in malaria vaccinees. Typing and subtyping by PCR technique and oligonucleotides. Parasite Immunol. 1991, 13, 201-210.
34. Urquiza, M.; Rodriguez, L. E.; Suarez, J. E.; Guzman, F.; Ocampo, M.; Curtidor, H.; Segura, C.; Trujillo, E.; Patarroyo, M. E. Identification of Plasmodium falciparum MSP-1 peptides able to bind to human red blood cells. Parasite Immunol. 1996, 18, 515-526.
35. Rodriguez, L. E.; Urquiza, M.; Ocampo, M.; Suarez, J.; Curtidor, H.; Guzman, F.; Vargas, L. E.; Trivinos, M.; Rosas, M.; Patarroyo, M. E. Plasmodium falciparum EBA-175 kDa protein peptides which bind to human red blood cells. Parasitology 2000, 120 (Part 3), 225-235.
36. Ocampo, M.; Urquiza, M.; Guzman, F.; Rodriguez, L. E.; Suarez, J.; Curtidor, H.; Rosas, J.; Diaz, M.; Patarroyo, M. E. Two MSA 2 peptides that bind to human red blood cells are relevant to Plasmodium falciparum merozoite invasion. J. Pept. Res. 2000, 55, 216-223.
37. Urquiza, M.; Suarez, J. E.; Cardenas, C.; Lopez, R.; Puentes, A.; Chavez, F.; Calvo, J. C.; Patarroyo, M. E. Plasmodium falciparum AMA-1 erythrocyte binding peptides implicate AMA-1 as erythrocyte binding protein. Vaccine 2000, 19, 508-513.
38. Rodriguez, L. E.; Ocampo, M.; Vera, R.; Puentes, A.; Lopez, R.; Garcia, J.; Curtidor, H.; Valbuena, J.; Suarez, J.; Rosas, J.; Rivera, Z.; Urquiza, M.; Patarroyo, M. E. Plasmodium falciparum EBA-140 kDa protein peptides that bind to human red blood cells. J. Pept. Res. 2003, 62, 175-184.
39. Rodriguez, L. E.; Curtidor, H.; Ocampo, M.; Garcia, J.; Puentes, A.; Valbuena, J.; Vera, R.; Lopez, R.; Patarroyo, M. E. Identifying Plasmodium falciparum merozoite surface antigen 3 (MSP3) protein peptides that bind specifically to erythrocytes and inhibit merozoite invasion. Protein Sci. 2005, 14, 1778-1786.
40. Vera-Bravo, R.; Valbuena, J. J.; Ocampo, M.; Garcia, J. E.; Rodriguez, L. E.; Puentes, A.; Lopez, R.; Curtidor, H.; Torres, E.; Trujillo, M.; Tovar, D. R.; Patarroyo, M. A.; Patarroyo, M. E. Amino terminal peptides from the Plasmodium falciparum EBA-181/JESEBL protein bind specifically to erythrocytes and inhibit in vitro merozoite invasion. Biochimie 2005, 87, 425-436.
41. Espejo, F.; Cubillos, M.; Salazar, L. M.; Guzman, F.; Urquiza, M.; Ocampo, M.; Silva, Y.; Rodriguez, R.; Lioy, E.; Patarroyo, M. E. Structure, immunogenicity, and protectivity relationship for the 1585 malarial peptide and its substitution analogues. Angew. Chem., Int. Ed. 2001, 40, 4654-4657.
42. Patarroyo, M. E.; Alba, M. P.; Vargas, L. E.; Silva, Y.; Rosas, J.; Rodriguez, R. Peptides inducing short-lived antibody responses against Plasmodium falciparum malaria have shorter structures and are read in a different MHC II functional register. Biochemistry 2005, 44, 6745-6754.
43. Patarroyo, M. E.; Salazar, L. M.; Cifuentes, G.; Lozano, J. M.; Delgado, G.; Rivera, Z.; Rosas, J.; Vargas, L. E. Protective cellular immunity against P. falciparum malaria merozoites is associated with a different P7 and P8 residue orientation in the MHC-peptide-TCR complex. Biochimie 2006, 88, 219-230.
44. Cifuentes, G.; Guzman, F.; Alba, M. P.; Salazar, L. M.; Patarroyo, M. E. Analysis of a Plasmodium falciparum EBA-175 peptide with high binding capacity to erythrocytes and their analogues using 1H NMR. J. Struct. Biol. 2003, 141, 115-21.
45. Tolia, N. H.; Enemark, E. J.; Sim, B. K.; Joshua-Tor, L. Structural basis for the EBA-175 erythrocyte invasion pathway of the malaria parasite Plasmodium falciparum. Cell 2005, 122, 183-193.
46. Stern, L. J.; Brown, J. H.; Jardetzky, T. S.; Gorga, J. C.; Urban, R. G.; Strominger, J. L.; Wiley, D. C. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 1994, 368, 215-221.
47. Dessen, A.; Lawrence, C. M.; Cupo, S.; Zaller, D. M.; Wiley, D. C. X-ray crystal structure of HLA-DR4 (DRA*0101, DRB1*0401) complexed with a peptide from human collagen II. Immunity 1997, 7, 473-481.
48. Jones, E. Y.; Fugger, L.; Strominger, J. L.; Siebold, C. MHC class II proteins and disease: A structural perspective. Nat. Rev. Immunol. 2006, 6, 271-282.
49. Rudolph, M. G.; Wilson, I. A. The specificity of TCR/pMHC interaction. Curr. Opin. Immunol. 2002, 14, 52-65.
50. Bermudez, A.; Cifuentes, G.; Guzman, F.; Salazar, L. M.; Patarroyo, M. E. Immunogenicity and protectivity of Plasmodium falciparum EBA-175 peptide and its analog is associated with α-helical region shortening and displacement. Biol. Chem. 2003, 384, 1443-1450.
51. Cifuentes, G.; Espejo, F.; Vargas, L. E.; Parra, C.; Vanegas, M.; Patarroyo, M. E. Orientating peptide residues and increasing the distance between pockets to enable fitting into MHC-TCR complex determine protection against malaria. Biochemistry 2004, 43, 6545-6553.
52. Cifuentes, G.; Patarroyo, M. E.; Urquiza, M.; Ramirez, L. E.; Reyes, C.; Rodriguez, R. Distorting malaria peptide backbone structure to enable fitting into MHC class II molecules renders modified peptides immunogenic and protective. J. Med. Chem. 2003, 46, 2250-2253.
53. Cubillos, M.; Alba, M. P.; Bermudez, A.; Trujillo, M.; Patarroyo, M. E. Plasmodium falciparum SERA protein peptide analogues having short helical regions induce protection against malaria. Biochimie 2003, 85, 651-657.
54. Cubillos, M.; Salazar, L. M.; Torres, L.; Patarroyo, M. E. Protection against experimental P. falciparum malaria is associated with short AMA-1 peptide analogue α-helical structures. Biochimie 2002, 84, 1181-1188.
55. Patarroyo, M. E.; Cifuentes, G.; Salazar, L. M.; Espejo, F.; Alba, M. P.; Bermudez, A. Based on HLA-DR beta1* allele binding specificities, striking differences in distance and TCR contacting residue orientation can be observed in modified protection-inducing malarial synthetic peptides. Curr. Med. Chem. 2005, 12, 2849-2865.
56. Patarroyo, M. E.; Cifuentes, G.; Vargas, L. E.; Rosas, J. Structural modifications enable conserved peptides to fit into MHC molecules thus inducing protection against malaria. ChemBioChem 2004, 5, 1588-1593.
57. Purmova, J.; Salazar, L. M.; Espejo, F.; Torres, M. H.; Cubillos, M.; Torres, E.; Lopez, Y.; Rodriguez, R.; Patarroyo, M. E. NMR structure of Plasmodium falciparum malaria peptide correlates with protective immunity. Biochim. Biophys. Acta 2002, 1571, 27-33.
58. Torres, M. H.; Salazar, L. M.; Vanegas, M.; Guzman, F.; Rodriguez, R.; Silva, Y.; Rosas, J.; Patarroyo, M. E. Modified merozoite surface protein-1 peptides with short alpha helical regions are associated with inducing protection against malaria. Eur. J. Biochem. 2003, 270, 3946-3952.
59. Garcia, J. E.; Puentes, A.; Suarez, J.; Lopez, R.; Vera, R.; Rodriguez, L. E.; Ocampo, M.; Curtidor, H.; Guzman, F.; Urquiza, M.; Patarroyo, M. E. Hepatitis C virus (HCV) E1 and E2 protein regions that specifically bind to HepG2 cells. J. Hepatol. 2002, 36, 254-262.
60. Ocampo, M.; Vera, R.; Eduardo Rodriguez, L.; Curtidor, H.; Urquiza, M.; Suarez, J.; Garcia, J.; Puentes, A.; Lopez, R.; Trujillo, M.; Torres, E.; Patarroyo, M. E. Plasmodium vivax Duffy binding protein peptides specifically bind to reticulocytes. Peptides 2002, 23, 13-22.
61. Urquiza, M.; Lopez, R.; Patino, H.; Rosas, J. E.; Patarroyo, M. E. Identification of three gp350/220 regions involved in Epstein-Barr virus invasion of host cells. J. Biol. Chem. 2005, 280, 35598-35605.
62. Plaza, D. F.; Curtidor, H.; Patarroyo M. A.; Chapeton, J. A.; Reyes C.; Barreto, J.; Patarroyo, M. E. The Mycobacterium tuberculosis membrane protein Rv2560-biochemical and functional studies. FEBS J. 2007, in press.
63. Snow, R. W.; Guerra, C. A.; Noor, A. M.; Myint, H. Y.; Hay, S. I. The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 2005, 434, 214-217.
64. Patarroyo, M. E.; Cifuentes, G.; Baquero, J. Comparative molecular and three-dimensional analysis of the peptide-MHC II binding region in both human and Aotus MHC-DRB molecules confirms their usefulness in antimalarial vaccine development. Immunogenetics 2006, 58, 598-606.